1. Resistance to cytostatic drugs at the cellular level

   • C. P. J. Vendrik
   • J. J. Bergers
   • P. A. Steerenberg

   Review Pages: 413 - 429

2. In vitro interactions between platinum analogues in human ovarian-carcinoma cell lines

   • Raymond P. Perez
   • Kimberly M. Perez
   • Thomas C. Hamilton

   Original Articles Pages: 430 - 434

3. Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer

   • Joseph Aisner
   • Margaret Y. Whitacre
   • Michael Perry

   Original Articles Pages: 435 - 438

4. Comparison of the blood-brain barrier and liver penetration of acridine antitumor drugs

   • Eain M. Cornford
   • Deborah Young
   • James W. Paxton

   Original Articles Pages: 439 - 444

5. Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein

   • Gini F. Fleming
   • Jacqueline M. Amato
   • Ahmad R. Safa

   Original Articles Pages: 445 - 449

6. Dose-dependent disposition kinetics and tissue accumulation of boron after intravenous injections of sodium mercaptoundecahydrododecaborate in rabbits

   • E. Buchar
   • S. Bednářová
   • I. Janků

   Original Articles Pages: 450 - 454

7. Deoxypyrimidine-induced inhibition of the cytokinetic effects of 1-β-d-arabinofuranosyluracil

   • Bangaru Chandrasekaran
   • Timothy E. Kute
   • Robert L. Capizzi

   Original Articles Pages: 455 - 460

8. Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations: a comparative study using cisplatin and carboplatin

   • Charles Fournier
   • Bernard Hecquet
   • David Khayat

   Original Articles Pages: 461 - 466

9. The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278

   • Marco Treskes
   • Ulbe Holwerda
   • Wim J. F. van der Vijgh

   Original Articles Pages: 467 - 470

10. Mechanisms of resistance to 6-thioguanine in a murine pancreatic tumor

    • Bih-Fang Pan
    • Teresa S. Priebe
    • J. Arly Nelson

    Original Articles Pages: 471 - 474

11. Unusual dynamics of killing of cultured lewis lung cells by the DNA-intercalating antitumour agentN-[2-(dimethylamino)ethyl]acridine-4-carboxamide

    • Andrea Haldane
    • Graeme J. Finlay
    • Bruce C. Baguley

    Original Articles Pages: 475 - 479

12. Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration

    • J. Dieter Nagel
    • Freek J. Varossieau
    • J. Gordon McVie

    Original Articles Pages: 480 - 484

13. Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02

    • Teresa S. Priebe
    • Edward N. Atkinson
    • J. Arly Nelson

    Original Articles Pages: 485 - 489

14. Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumors

    • K. Mross
    • K. Hamm
    • D. K. Hossfeld

    Original Articles Pages: 490 - 494

15. Non-immunological release of histamine from rat mast cells elicited by antineoplastic agents

    • L. M. Botana
    • E. Arnaez
    • A. Cabado

    Short Communication Pages: 495 - 498